Antibiofilm, Antimicrobial, and Anti‐inflammatory Potential of Rubus chamaemorus Rhizome, Leaf, and Fruit Extracts
Chemistry & Biodiversity · 2026-07 · 23 (7)
DOI: 10.1002/cbdv.71479 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 09.07.2026. Verfasst von Hildegard Kieninger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biology, Institute of Pharmacy, Partner in the Greifswald Mire Center, University of Greifswald, Greifswald, Germany. Hauptthemen laut MEDLINE: Plant Extracts, Biofilms, Anti-Bacterial Agents, Anti-Inflammatory Agents. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Federal Ministry for Food and Agriculture (BMEL)/Fachagentur Nachwachsende Rohstoffe e. V. (FNR).
Abstract (Originalsprache)
The global rise of antimicrobial resistance is concomitant with an increasing prevalence of chronic wound infections. Medicinal plants are a promising source of novel therapeutic agents. Rubus chamaemorus , a plant native to Northern Europe traditionally used for wound healing, is one of them. Dried, powdered rhizomes, leaves, and fruits of R. chamaemorus were extracted with dichloromethane, methanol, and water. The extracts were screened for antibacterial and antifungal activity. Main compounds were identified using liquid chromatography‐mass spectrometry (LC‐MS). Biofilm inhibition was assessed using multidrug‐resistant Escherichia coli . Cytotoxicity against HaCaT cells, inhibition of 5‐lipoxygenase (5‐LOX) product formation, chelating, and antioxidant properties were determined. While the rhizome and fruit extracts demonstrated no relevant biological activities, the methanolic leaf extract exhibited a low minimal biofilm inhibitory concentration (MBIC = 30 µg/mL) and a potent 5‐LOX inhibition (IC 50 = 1.5 ± 0.5 µg/mL). These properties are likely linked to the pronounced chelating and antioxidant properties of the extract. No cytotoxicity was observed in HaCaT cells and human primary monocytes (up to 200 and 30 µg/mL, respectively). LC‐MS analysis of the leaf extracts identified flavonoid glycosides as predominant compounds. These findings support the plant's traditional use in wound healing. Bioactivity‐guided fractionation is imperative to identify and characterize the active compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Biology, Institute of Pharmacy, Partner in the Greifswald Mire Center, University of Greifswald, Greifswald, Germany.
- Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.
ORCID-Profile: Hildegard Kieninger
Förderung
- German Federal Ministry for Food and Agriculture (BMEL)/Fachagentur Nachwachsende Rohstoffe e. V. (FNR)
Zitieren
APA
Kieninger, H., Koenig, S., Schultze, N., Garscha, U., Guenther, S., & Schulze, C. (2026). Antibiofilm, Antimicrobial, and Anti‐inflammatory Potential of Rubus chamaemorus Rhizome, Leaf, and Fruit Extracts. Chemistry & Biodiversity, 23(7). https://doi.org/10.1002/cbdv.71479
Vancouver
Kieninger H, Koenig S, Schultze N, Garscha U, Guenther S, Schulze C. Antibiofilm, Antimicrobial, and Anti‐inflammatory Potential of Rubus chamaemorus Rhizome, Leaf, and Fruit Extracts. Chemistry & Biodiversity. 2026;23(7). doi:10.1002/cbdv.71479
BibTeX
@article{Kieninger2026,
author = {Kieninger, Hildegard and Koenig, Stefanie and Schultze, Nadin and Garscha, Ulrike and Guenther, Sebastian and Schulze, Christian},
title = {Antibiofilm, Antimicrobial, and Anti‐inflammatory Potential of Rubus chamaemorus Rhizome, Leaf, and Fruit Extracts},
journal = {Chemistry & Biodiversity},
year = {2026},
volume = {23},
number = {7},
doi = {10.1002/cbdv.71479}
}
EUVIMED